Israel is establishing a consortium to make CRISPR genome editing more precise. Israel’s Innovation Authority has allocated NIS 36 million to CRISPR-IL, for the country’s academic institutions and bio-techs to use AI to advance the technology for repairing disease-causing mutations.
DNA editing to cure diseases
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.